| 元智大學 |
2011-10 |
High Reversibility of Li Intercalation and De-intercalation in MnO-attached Graphene Anodes for Li-ion Batteries
|
Chien-Te Hsieh; C.-Y. Lin; J.-Y. Lin |
| 國立交通大學 |
2020-07-01T05:21:13Z |
High reversible Li plating and stripping by in-situ construction a multifunctional lithium-pinned array
|
Xu, Pan; Lin, Xiaodong; Hu, Xinyu; Cui, Xueyang; Fan, Xiaoxiang; Sun, Cui; Xu, Xiaoming; Chang, Jeng-Kuei; Fan, Jingmin; Yuan, Ruming; Mao, Bingwei; Dong, Quanfeng; Zheng, Mingsen |
| 國立交通大學 |
2014-12-12T02:00:25Z |
High RF Performance GaAs Metamorphic HEMTs with 90 nm Sidewall Gate
|
彭怡瑄; 張翼 |
| 元智大學 |
2010-10 |
High risk consumption: a case study on jade collection in Taiwan
|
Yu Ying Lee |
| 臺大學術典藏 |
2021-07-03T03:33:21Z |
High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy
|
Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2020-11-03T08:19:40Z |
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy
|
Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:10Z |
High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy
|
Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:15Z |
High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy
|
Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:21Z |
High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy
|
Chang W.-Y; | Chiu Y.-C; | Chiu F.-W; | Hsu Y.-C; | Tseng T.-C; | Cheng P.-N; | Yang S.-S; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T05:16:27Z |
High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy
|
Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:31:03Z |
High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy
|
Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; CHUN-JEN LIU; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 中山醫學大學 |
2020 |
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy
|
Chang, WY; Chiu, YC; Chiu, FW; Hsu, YC; Tseng, TC; Cheng, PN; Yang, SS; Liu, CJ; Su, TH; Yang, HC; Liu, CH; Chen, PJ; Chen, DS; Kao, JH |
| 國立成功大學 |
2020 |
High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy
|
Chang, W.-Y.;Chiu, Y.-C.;Chiu, F.-W.;Hsu, Y.-C.;Tseng, Tseng T.-C.;Cheng, P.-N.;Yang, S.-S.;Liu, C.-J.;Su, T.-H.;Yang, H.-C.;Liu, C.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H. |
| 國立成功大學 |
2012-06 |
High risk of cross-reactivity between vancomycin and sequential teicoplanin therapy
|
Hsiao, S. -H.; Chou, C. -H.; Lin, W. -L.; Lee, E. -J.; Liao, L. -H.; Chang, H. -J.; Yeh, P. -Y.; Lin, C. -Y.; Wu, T. -J. |
| 中國醫藥大學 |
2015-12 |
High Risk of Depressive Disorders in Patients With Gout: A Nationwide Population-Based Cohort Study.
|
(Yung-Chieh Yen);林橙莉;(Ming-Chia Lin);梁基安(Ji-An Liang);高嘉鴻(Chia-Hung Kao)* |
| 中國醫藥大學 |
2015-06 |
High risk of developing subsequent epilepsy in young adults with migraine: a nationwide population-based cohort study in Taiwan.
|
(T. HARNOD);王昱喬;高嘉鴻(Chia-Hung Kao)* |
| 臺北醫學大學 |
2013 |
High Risk of Gastrointestinal Hemorrhage in Patients With Epilepsy: A Nationwide Cohort Study
|
CC, Yeh;HH, Wang;YC, Chou;CJ, Hu;WH, Chou;TL, Chen;CC, Liao |
| 臺北醫學大學 |
2013 |
High Risk of Gastrointestinal Hemorrhage in Patients With Epilepsy: A Nationwide Cohort Study
|
CC, Yeh;HH, Wang;YC, Chou;CJ, Hu;WH, Chou;TL, Chen;CC, Liao |
| 臺北醫學大學 |
2013 |
High risk of gastrointestinal hemorrhage in patients with epilepsy: a nationwide cohort study
|
Yeh, CC;Wang, HH;Chou, YC;Hu, CJ;Chou, WH;Chen, TL;Liao, CC |
| 臺北醫學大學 |
2013 |
High risk of gastrointestinal hemorrhage in patients with epilepsy: a nationwide cohort study
|
Yeh, CC;Wang, HH;Chou, YC;Hu, CJ;Chou, WH;Chen, TL;Liao, CC |
| 中國醫藥大學 |
2013-09 |
High Risk of Gastrointestinal Hemorrhage in Patients With Epilepsy: A Nationwide Cohort Study.
|
葉俊杰(Chun-Chieh Yeh);王煌輝;周怡君(Yi-Chun Chou);胡朝榮(Chaur-Jong Hu);周文心(Wan-Hsin Chou);陳大樑(Ta-Liang Chen);廖建彰(Chien-Chang Liao)* |
| 臺大學術典藏 |
2021-01-04T12:12:32Z |
High risk of hepatitis B reactivation among patients with acute myeloid leukemia
|
HWEI-FANG TIEN; Tsay W.; Sheng W.-H.; Tang J.-L.; Yao M.; Chou W.-C.; Cheng A.; Huang S.-Y.; Chen C.-Y. |
| 臺大學術典藏 |
2021-02-05T06:29:27Z |
High risk of hepatitis B reactivation among patients with acute myeloid leukemia
|
Chen C.-Y.; Huang S.-Y.; Cheng A.; WEN-CHIEN CHOU; Yao M.; Tang J.-L.; Tsay W.; Sheng W.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:30Z |
High risk of hepatitis B reactivation among patients with acute myeloid leukemia
|
Chen C.-Y.; Huang S.-Y.; Cheng A.; Chou W.-C.; Yao M.; JIH-LUH TANG; Tsay W.; Sheng W.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-26T01:59:41Z |
High risk of hepatitis B reactivation among patients with acute myeloid leukemia
|
Chen C.-Y.;Huang S.-Y.;Cheng A.;Chou W.-C.;Yao M.;Tang J.-L.;Tsay W.;Wang-Huei Sheng;Tien H.-F.; Chen C.-Y.; Huang S.-Y.; Cheng A.; Chou W.-C.; Yao M.; Tang J.-L.; Tsay W.; WANG-HUEI SHENG; Tien H.-F. |
